As a trusted, global-compliant partner to 300+ biotechs/pharmas, HYQURE focuses on biosafety testing specializing in biologics and cell/gene therapy matching top global providers. Our core competencies include:

1.             Virus Clearance Validation

2.             Cell Bank Characterization

3.             Commercial Batch Release Testing

4.             Replication-Competent Virus Assays (RCL, rcAAV, RCR, RCA)

5.             Host Cell Protein/Residual DNA Detection Kits

The capability of methodologies and quality systems we’ve built have been recognized by global regulatory authorities. Up until now, we have had more than100 successfully approved IND or BLA cases and more than 40 of them have been approved by FDA, EMA, TGA etc. and we have established stable collaboration with more than 300 global clients with their over 400 pipelines.